(Q44511825)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12859222%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Economic model of first-line drug strategies to achieve recommended glycaemic control in newly diagnosed type 2 diabetes mellitus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12859222%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12859222%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Joe W Ramsdell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12859222%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Seth N Braunstein

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12859222%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Jennifer M Stephens

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12859222%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Christopher F Bell

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12859222%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Marc F Botteman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12859222%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12859222%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12859222%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12859222%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12859222%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

819-837

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12859222%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00019053-200321110-00005

5 November 2019

exact match

0 references

cites work

Individual sulfonylureas and serious hypoglycemia in older people.

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00019053-200321110-00005

A short-term cost-of-treatment model for type 2 diabetes: comparison of glipizide gastrointestinal therapeutic system, metformin, and acarbose

21 January 2018

1 reference

12 December 2020

Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes.

1 reference

12 December 2020

Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

1 reference

12 December 2020

Repaglinide/troglitazone combination therapy: improved glycemic control in type 2 diabetes.

1 reference

12 December 2020

Formulary development at Regence BlueShield--a formula for success

1 reference

12 December 2020

Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastro

1 reference

12 December 2020

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

1 reference

12 December 2020

Antihyperglycaemic efficacy, response prediction and dose-response relations of treatment with metformin and sulphonylurea, alone and in primary combination.

1 reference

12 December 2020

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

1 reference

12 December 2020

Doing the right thing: new guidelines for glycemic control

1 reference

12 December 2020

Hypoglycemia in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus

1 reference

12 December 2020

A comparison of repaglinide and glibenclamide in the treatment of type 2 diabetic patients previously treated with sulphonylureas.

1 reference

12 December 2020

Oral antihyperglycemic therapy for type 2 diabetes: clinical applications

1 reference

12 December 2020

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

1 reference

12 December 2020

Oral antihyperglycemic therapy for type 2 diabetes: scientific review

1 reference

12 December 2020

Type 2 diabetes: stepped-care approach to patient management

1 reference

12 December 2020

Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.

1 reference

12 December 2020

Foot care assessment in patients with diabetes: a screening algorithm for patient education and referral.

1 reference

12 December 2020

Cost effectiveness of combination therapy. Based on a presentation by Daniel Hilleman, PharmD

1 reference

12 December 2020

Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes

1 reference

12 December 2020

Repaglinide in type 2 diabetes: a 24-week, fixed-dose efficacy and safety study

1 reference

12 December 2020

Oral agent therapy in the treatment of type 2 diabetes.

1 reference

12 December 2020

Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications

1 reference

12 December 2020

1 reference

12 December 2020

Mild-to-moderate uncomplicated hypertension: further analysis of a cost-effectiveness study of five drugs.

1 reference

12 December 2020

An economic evaluation of the JNC hypertension guidelines using data from a randomized controlled trial. Joint National Committee.

1 reference

12 December 2020

Repaglinide versus glyburide: a one-year comparison trial.

1 reference

12 December 2020

Evaluating Medication Use for Continuous Quality Improvement in Diabetes Care

1 reference

12 December 2020

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

12 December 2020

Resource utilization and costs of care in the diabetes control and complications trial

1 reference

12 December 2020

A short term cost-effectiveness model for oral antidiabetic medicines in Europe

1 reference

12 December 2020